Abstract: DNA sequences can be used for the analysis of genetic variation and gene function. The high-throughput sequencing techniques that have been developed over the past three years can read as many as one billion bases per run, and are far less expensive than the traditional Sanger sequencing method. Therefore, the high-throughput sequencing has been applied extensively to genomic analyses, such as screening for mutations, construction of genomic methylation maps, and the study of DNA-protein interactions. Although they have only been available for a short period, high-throughput sequencing techniques are profoundly affecting many of the life sciences, and are opening out new potential avenues of research. With the highly-developed commercial high-throughput sequencing platforms, each laboratory has the opportunity to explore this research field. Therefore, in this paper, we have focused on commercially-popular high-throughput sequencing techniques and the ways in which they have been applied over the past three years.
Introduction
In 1977, Sanger developed the dideoxy chain-termination method of DNA sequencing. During the subsequent 20 years, this method was predominant within the sequencing field and it was used to construct draft genome sequences for many important species, such as humans, rats, Arabidopsis and rice. However, with the Sanger method, only 1,000 base pairs can be read per run, which makes the analysis of whole genomes too expensive for the common laboratory. For example, the cost of construction of the draft human genome sequence was over 300 million US dollars. Therefore, it is unrealistic to promote the Sanger method for applications, such as the diagnosis of genetic diseases. With the development of high-throughput sequencing technologies over the past three years, the dominant position of the Sanger method has begun to be challenged (Goldberg et al. 2006; Hutchison 2007) . The Solexa system, which was developed by Illumina (Bennett 2004; Bennett et al. 2005) , and the pyrosequencing system, which was developed by 454 Life Sciences (hereinafter referred to as 454 sequencing or the 454 system) (Margulies et al. 2005) , are two typical examples of highthroughput sequencing technologies. These sequencing platforms can read as many as one billion base pairs per run (Solexa sequencing) and are markedly less expensive than conventional techniques, which makes the goal of a "1000-dollar genome" more realistic (Bennett et al. 2005; Mardis 2006; Service 2006; Ryan et al. 2007 ). Therefore, these technologies have been applied extensively to genomic analyses such as mutation screening, construction of genomic methylation maps, and the study of DNA-protein interactions.
In this paper, we review the significant progress that has been made in the field of high-throughput sequencing in the short time period of the past three years. We focus on commercially-popular sequencing platforms because they are available to, and therefore of interest to, the everyday scientist.
Brief introduction to two typical commercial high-throughput sequencing techniques
When compared to classic Sanger sequencing, the most obvious advantage of high-throughput sequencing is its ability to extract information about billions of base pairs per run. However, the DNA fragments that arise during high-throughput sequencing are much shorter than those from Sanger sequencing, which means that it is more difficult to assemble them. Therefore, highthroughput sequencing is used mainly for the resequencing of genomes, namely to screen for differences from a reference genome, such as in the identification of single nucleotide polymorphisms. At present, the commercially-developed high-throughput platforms in-clude the Solexa system (Bennett 2004; Bennett et al. 2005 ) and the 454 system (Margulies et al. 2005) . These two systems are based on the principle of shotgun sequencing. They remove the need to clone the DNA fragments into Escherichia coli or other host cells for amplification, and therefore avoid the introduction of errors that are derived from the base composition bias of the host genome (Hall 2007) .
The method and principles of the Solexa system are as follows. Genomic DNA is sonicated to produce random DNA fragments, and adapters are ligated to both ends of the fragments. Then, the fragments are bound to a solid surface, upon which solid-phase amplification is performed to form DNA clusters. Labeled reversible terminators are added together with DNA polymerase to initiate the first cycle of the synthesis reaction. The incorporated base is identified by laser scanning, and then the blocked terminus is removed and the next synthesis cycle is commenced. This process is repeated until the entire base composition of the DNA fragments has been obtained.
The 454 system involves a similar working principle as that of the Solexa system. The difference is the lack of a protecting group for the termination reaction. Base incorporation is monitored by a chemiluminescence reaction that is caused by the pyrophosphate that is released during the sequencing process. The sequenced length is monitored by measuring the amount of released pyrophosphate. The 454 system can read 400,000 fragments of more than 100 bases per run. The Solexa system can produce 40 million readings of approximately 25-35 bases. Most sequences of approximately 30 bases can be aligned unambiguously with a reference genome sequence (Bentley 2006) . Therefore, the Solexa system is uniquely suited to analyses that involve calculating the frequency of occurrence of certain sequences, for example the statistical analysis of single nucleotide polymorphisms (Blow 2007) . In contrast, the 454 system can produce longer DNA fragments, which facilitates fragment assembly (Ng et al. 2006) . However, the 454 system is prone to errors in the estimation of the length of the sequenced fragment, is restricted in its ability to detect the insertion or deletion of a single base pair (Hutchison 2007) , and is not reliable for the sequencing of homopolymers, especially for a repeat of 5-8 copies of the same base pair (Bentley 2006; Moore et al. 2006 ). For example, many errors occurred in the detection of homopolymers when the 454 system was used to scan the genome of the Bacteroidetes species Sulcia muelleri. It was possible to correct 125 of these errors using the Solexa system (McCutcheon & Moran 2007) , which shows that this method is better suited to sequencing homopolymeric regions. Therefore, these two high-throughput sequencing systems both have their own advantages and can be combined to overcome the disadvantages of each system (Hutchison 2007) .
In addition to these commercially-developed highthroughput sequencing technologies, other techniques are under development, such as: (1) Polony sequencing, which has an error rate as low as 1/1,000,000 ((Shendure et al. 2005) ; (2) a microfabricated bioprocessor for integrated nanoliter-scale Sanger sequencing (Blazej et al. 2006) ; (3) the SOLiD sequencing system, which is based on a ligation reaction instead of the traditional polymerization reaction and can produce raw data of 8 Gb of sequence and valid data of 4 Gb (i.e. greater than the length of the human genome) (Blow 2007) ; and (4) a single-molecule sequencing technique, which excludes the need for PCR amplification (Harris et al. 2008 ).
Applications of commercial high-throughput sequencing in genome analysis
Re-sequencing target sites Most plants and animals, including humans, have huge genomes. Even using high-throughput sequencing techniques, it is still not realistic to sequence the genome of each individual in a population or species. From the viewpoint of biological function, it is also not necessary to sequence the entire genome. For example, the human genome is 2.85 Gb in size. However, 98% of this DNA is composed of repeat, intergenic and non-protein-coding sequences. Only the remaining 2% consists of highly variable regions that are related to specific functions. The amount of sequencing that needs to be performed can be reduced greatly by focusing on specific target sites within the genome. These target sites include DNA methylation regions, protein-binding sites on the DNA, and nuclease-sensitive regions (Wold & Myers 2008) . However, this approach has been limited by the difficulty in isolating a sufficiently large number of target sites to exploit thoroughly the powerful ability of highthroughput sequencing (Porreca et al. 2007) . Recently, many researchers have proposed novel approaches to resolve this problem and have made outstanding progresses.
If there are a limited number of target sites within a DNA sample from a mixed population, PCR amplification of the target sites can be performed to isolate and enrich the sites of interest. These sites can then be analyzed by high-throughput sequencing. Romeo et al. (2007) applied this strategy to analyze polymorphisms within the lipid-metabolism-related gene angiopoietinlike protein 4 (ANGPTL4), and the possible relationship between certain variants and plasma levels of triglycerides in a population of 3551 individuals. The approach of Romeo et al. (2007) initiated the study of complex traits in a large population by re-sequencing, and is expected to be utilized extensively in subsequent studies. Tartaglia et al. (2007) scanned the 23 exons of the SOS1 gene, mutations in which cause Noonan syndrome (a common genetic cause of congenital heart disease) in 129 individuals by high-throughput sequencing. Analysis of the relationship between phenotype and genotype showed that different mutations in SOS1 did not give rise to changes in the symptoms of Noonan syndrome but some distinctive characteristics, such as ectodermal abnormality, were associated with specific variants.
Some complex phenotypes or diseases such as cancer may be controlled by multiple genes. Traditionally, the relevant genetic information is obtained using primers that are designed to amplify all the target sites, and by comparing products that have been amplified from normal and abnormal gene pools. When the population is large, the analysis of complex phenotypes that involve multiple genes by these traditional strategies requires substantial manpower and is timeconsuming. For example, to study 22 types of human breast and colorectal cancer, one needs to synthesize at least 135,483 different nucleotide primers and perform 300 million rounds of PCR (Sjoblom et al. 2006) . It is possible that this immense workload and expenditure can be reduced by high-throughput sequencing. However, to achieve this, a large number of target sites must be isolated from genomes. Olson (2007) has proposed isolating exons from the human genome using a high-density microarray (this would allow the isolation of approximately 200,000 sites, which would correspond to 55 Mb, i.e. 2% of the entire human genome). Hodges et al. (2007) realized the idea of Olson (2007): they captured 98% of exons in the entire genome on a microarray, sequenced the fragments that were hybridized to the array by high-throughput sequencing, and analyzed the variation in the exon sequences after mapping the sequenced fragments back onto the reference genome. The outstanding merit of Hodges et al. (2007) design is the combination of high-throughput sequencing and the flexibility of target site selection by microarray, which enables the re-sequencing of batch target sites. However, enrichment by microarray still has some limitations in practice, for example certain sites are rarely enriched due to the non-uniform capture of target sites (Porreca et al. 2007 ). In addition, in order to design such a microarray, the sequence of the reference genome must be known. However, genome sequencing projects have not been initiated for the majority of organisms, and therefore the application of the method of Hodges et al (2007) is mainly limited to model organisms such as human, mice, Arabidopsis and rice.
Chromatin immunoprecipitation (ChIP) with an appropriate antibody can also enrich target sites effectively, and does not require the design and synthesis of thousands of primers and probes. Johnson et al. (2007) first proposed the ChIPSeq technique to detect interactions between proteins and specific DNA sequences. The main principles of their design are as follows: an antibody against a DNA-binding protein is used to precipitate and enrich DNA sites that are bound by this protein; the fragments are sequenced by high-throughput sequencing; and after the sequences of these proteinbinding sites are aligned with the reference genome, the features of the sites on the genomic DNA can be analyzed. Before ChIPSeq, the ChIP-chip technique (chromatin immunoprecipitation followed by hybridization to a microarray) had been employed extensively to study protein-genomic DNA interactions (Johnson et al. 2008 ). Compared to ChIP-chip, ChIPSeq has outstanding advantages: it has the potential to allow analysis of target sites throughout the whole genome instead of only designed sites; a smaller DNA sample volume is required and there is no need for DNA amplification, which avoids corresponding errors; the output is a digital signal, i.e. it reveals the number of copies of a particular sequence in each sample; and it is less expensive (Fields 2007; Mikkelsen et al. 2007; Lang et al. 2008; Wold & Myers 2008) . Employing this design, Johnson et al. (2007) constructed a human genome map of 1946 target sites of the neuron-restrictive silencer factor, with a resolution as high as 50 bp. The maps that are constructed with the ChIPSeq technique have high sensitivity, specificity and statistical stability (Johnson et al. 2007; Robertson et al. 2007) . Only a few months after the ChIPSeq technique was proposed, it had been extended to the construction of genomescale DNA methylation maps for humans (Barski et al. 2007 ) and rats (Mikkelsen et al. 2007 ), maps of DNase I-sensitive sites (Boyle et al. 2008 ), a map of the binding sites of the transcription activator STAT1 (Robertson et al. 2007) , and a nucleosome site map (Schones et al. 2008) . The members of a large number of important protein families bind to genomic DNA, for example histones, DNA-repair-related proteins, and transcription factors, which suggests that the ChIPSeq technique will be widely applicable in the study of protein-genomic DNA interactions (Fields 2007; Mardis 2007; Wold & Myers 2008 ).
Recently, we described briefly how the ChIPSeq technique can be applied to the construction of genomic DNA methylation maps (Peng et al. 2008) . The genomic DNA is sonicated into fragments, the methylated DNA fragments are enriched by immunoprecipitation using a monoclonal antibody against methylcytosine, and the methylated cytosines are mapped onto the genome after Solexa sequencing. With the recently published BS-Seq method (Cokus et al. 2008 ) of genomic DNA methylation map construction, which is described below, each base pair of the genome must be sequenced. However, with ChIPSeq only the methylated sites need to be sequenced, which reduces the workload of sequencing. This makes ChIPSeq a valuable approach for the construction of methylation maps for species with large genomes, such as humans, rats and wheat. Recently, Li et al. (2008) published a methylated cytosine distribution map for rice chromosomes 4 and 10. This showed that the methylated fragments only represented approximately 15% of the chromosomal DNA. Therefore, the sequencing workload for the construction of a rice genomic DNA methylation map using ChIPSeq is approximately equivalent to one sixth of that with the BS-Seq method.
Re-sequencing of the whole genome Although high-throughput sequencing does decrease the cost of sequencing the genome (Blow 2007) , its operating costs are still relatively high. Therefore, the re-sequencing of whole genomes is mainly restricted to species with small genomes, such as bacteria and nematodes. Using the Solexa system, Hillier et al. (2008) analyzed genomic DNA polymorphism in Caenrohabditis elegans strain CB4858, and identified 45,539 single nucleotide polymorphisms and insertion/deletion mutations, which represent a polymorphism rate that is roughly equivalent to that reported previously (Denver et al. 2003) . Classic Sanger sequencing was used to verify these mutations, and this gave a coincidence rate of approximately 90% and a false negative rate (missed mutations) of only 3.75% (Hillier et al. 2008) . This shows that the Solexa system can be used effectively to survey mutations on a genome-wide scale. E. coli MG1655 was engineered to be deficient in tryptophan biosynthesis. After it had evolved for approximately 200 generations, its phenotype had obviously changed, which suggested that a genetic variation had occurred. Polony sequencing was used to scan the genome of strain MG1655 and the single-nucleotide change site was detected with a frequency of 98-100% ( (Shendure et al. 2005) . Similarly, using the 454 system, a large number of mutated sites, which are possibly related to phenotypic variation, were identified in the genome of Myxococcus xanthus (Velicer et al. 2006) . The Solexa and 454 systems were combined to analyze the genome of the Bacteroidetes species S. muelleri, and to examine its parallel genomic evolution with its host and a co-resident symbiont (McCutcheon & Moran 2007 ). This resulted in some different conclusions from those of previous studies. For example, the pathway of amino acid biosynthesis was complete in S. muelleri (McCutcheon & Moran 2007) , which suggested that S. muelleri may not have been dependent on its host or symbiont for amino acid biosynthesis, which was suggested previously. The above experiments show the following: (1) the short fragments that are produced by high-throughput sequencing do not obviously affect the ability to detect accurately mutations throughout the genome; and (2) although the accuracy of sequencing is not 100% (Margulies et al. 2005) , the large sequencing capacity allows multiple readings of the entire genome, and subsequent statistical analysis can partially exclude the errors that are derived from sequencing.
High-throughput sequencing can be used not only to survey DNA mutations within a specific genome, but also to analyze genetic diversity within a population. The large number of DNA fragments that are produced results in high detection sensitivity. For example, 454 sequencing shows that the population diversity of submarine microorganisms arises from a large number of low-abundance species, and the amount of diversity is far higher than reported previously (Sogin et al. 2006) . In that study, a total of 118,000 amplicons, which were derived from the highly variable V6 region of rRNA, were analyzed in samples from the Atlantic and Pacific Oceans. After aligning these sequences with known bacterial V6 sequences in databases, they were grouped into operational taxonomic units (OTUs) to determine the population diversity. All the samples consisted of more than 1,000 OTUs and most comprised more than 3,000 (Sogin et al. 2006) , which suggests that the bacterial population in the ocean biosphere is extremely complex. Similarly, using the 454 system, Edwards et al. (2006) analyzed two microbial populations from different sites within a deep mine (714 m below the surface), and obtained DNA sequence information of over 35 Mb. Diversity analysis using the 16S rRNA sequences showed that the population from the oxygen-containing environment consisted of more species than that from the environment without oxygen. Subsequently, the authors analyzed the physiological and metabolic differences between the members of the different microbial populations, by identifying the genes that were represented by the sequence fragments. The results showed that some metabolic pathways were more prevalent in the species that were found in particular populations (Edwards et al. 2006) . The outstanding significance of this study is that it applied high-throughput sequencing not only to the analysis of genetic diversity within a population, but also to the study of physiology and metabolism, and correlated these results with environmental differences. This research can act as a guide for similar subsequent studies. As the number of DNA fragments that are sequenced increases, more OTUs can be identified within a single microbial population (Sogin et al. 2006 ). This suggests that use of the Solexa system, which can detect more fragments per run, enhances the detection sensitivity. This is especially relevant for microbial samples from complex environments, which contain a greater number of species. In addition, the 454 system is prone to errors with particular types of DNA sequence (Bentley 2006; Moore et al. 2006) , and these errors may be mistaken for population genetic diversity (Hall 2007) . Therefore, we think that the Solexa system, which produces shorter DNA fragments, but with higher accuracy, will enhance the detection sensitivity and accuracy of genetic diversity analysis, and therefore, will be more suitable for the analysis of microbial species in complex environments.
Recently, Cokus et al. (2008) extended the application of high-throughput sequencing to Arabidopsis, which has a much larger genome than most microbes, and constructed a high-resolution genomic methylation map. Their approach is as follows. Unmethylated cytosine residues in the genome are converted to uracil with bisulfate, which leaves the methylated cytosine residues untouched. The genome is then randomly sequenced with the Solexa system, and the sequences obtained are compared with the reference sequence. The ratio of detection frequency between converted and unconverted cytosine residues represents the degree of methylation of the cytosine residues. This method is called BS-Seq due to the use of bisulphate and subsequent sequencing. Compared to the first Arabidopsis genomic methylation map that was constructed by Zhang et al. (2006) using the ChIP-chip technique, the resolution of the map that was constructed using the BS-Seq method was greatly enhanced, to a resolution of one base pair (Cokus et al. 2008) , which made it possible to define precisely the methylated region. For example, some DNA regions that had been considered not to be methylated when using the microarray-based technique (Zhang et 24 H. Peng & J. Zhang al. 2006; Zilberman et al. 2007) were in fact found to be methylated sparsely, by the BS-Seq technique (Cokus et al. 2008 ). Furthermore, a high resolution greatly facilitates detailed analysis of the distribution of methylated cytosine residues within the genome. For example, using the BS-Seq technique, methylated cytosine in the non-symmetric sequence context CHH (where H corresponds to A, T, G or C) have been found to be distributed periodically throughout the genome at a spacing of 10 bp (Cokus et al. 2008) . In animals, Dnmt3 methyltransferase is responsible for the methylation of two CG sites that are spaced 8-10 bp apart (Jia et al. 2007 ). In plants, DRM2 is the main enzyme that controls asymmetric methylation in Arabidopsis and it is a homologue of Dnmt3 (Cao et al. 2000) . Therefore, the authors deduced that this type of methyltransferase is conserved between plants and animals (Cokus et al. 2008) . The large amount of data that is produced by high-throughput sequencing makes it possible to construct methylation maps with a single-base-pair resolution, which in turn provides the foundation for the detailed discoveries that are described above.
Problems and prospects
Similarly to other novel technologies, there are still some limitations for high-throughput sequencing that need to be addressed step by step (Wold & Myers 2008) . The limitations at present include the following.
(1) The fragments that are produced are short (25-100 bp) and therefore, cannot be assembled to give a complete genome sequence (Edwards et al. 2006) . Repeat sequences cannot be aligned unambiguously with the reference genome (Blow 2007) . For example, approximately 15-20% of human DNA fragments cannot be aligned unambiguously with the human genome (Wold & Myers 2008) . Some novel technologies that produce longer fragments and give a higher sequencing speed are under development (Fredlake et al. 2008) , which may resolve this problem.
(2) Before the DNA fragments can be sequenced, PCR amplification must be performed to form DNA clusters. This introduces errors (Edwards et al. 2006; Harris et al. 2008 ) and therefore, the accuracy of this technique is lower than that of single-molecule sequencing methods (Bayley 2006; Harris et al. 2008) , such as reading the composition of a DNA molecule as it passes through a microhole (Storm et al. 2005a,b) .
(3) As a novel sequencing technology, the corresponding statistical methods for data analysis need to be developed and perfected. Otherwise, even papers that have been published in Science might be disputed (Forrest & Cavet 2007; Getz et al. 2007; Rubin & Green 2007) .
(4) Undoubtedly, the processing of such large amounts of data is dependent on the availability of appropriate computer programs. However, only a limited number of programs have been developed at present, for example, software for the analysis of genomic methylation patterns (Cokus et al. 2008) . High-throughput sequencing can be applied potentially to all types of organism and areas of research and more software are needed to analyze the resulting data.
High-throughput sequencing has only been developed during the last three years (Bennett et al. 2005) . However, the frequency of reports of its usage has increased over this time period, which shows what a valuable technique it is becoming. High-throughput sequencing technologies can be used for surveying entire genomes with high levels of accuracy, even to singlebase-pair resolution (Cokus et al. 2008) . Therefore, they have led to a range of novel discoveries in different fields. Because of the short period since their development, related studies have focused on improving the technical processes, and have rarely addressed fundamental biological questions, which leaves open a large field of research. The commercial high-throughput sequencing platforms not only provide each researcher with the opportunity to explore this research field, but can also enable expenditure on sequencing to be decreased gradually, even to a degree that is acceptable for routine laboratory procedures, such as the diagnosis of genetic diseases (Hall 2007) .
